Updated Jan 16, 2018

Default inno

Plant virus based nanoparticles as an adjuvant for the development of an efficient and low cost vaccine against malaria.

http://www.chuq.qc.ca/fr/

The innovation has no owner

CLAIM IT

Stage 2: Research & Development

Registered in Canada.

Focus Areas:

Health and Prevention & Vaccination

Health and Prevention & VaccinationSEE LESS

Implemented In:

India

IndiaSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

Despite years of intensive efforts using conventional approaches to vaccine design, there is currently no effective vaccine against malaria, so. new approaches are crucial.
How does your innovation work?
The ""Plant virus based nanoparticles as an adjuvant for the development of an efficient and low cost vaccine against malaria" project aims to use nanoparticles derived from papaya mosaic virus (PapMV-NP) as an adjuvant to develop a novel malaria vaccine that would be safe, efficacious and low-cost.

Milestones

Date Unknown
Created
Date Unknown
New Country Implemented In
India